Developer docs
API playgroundTry for free, no card

Search company profiles

Mcule

Full company profile

uuid0004lc3

Namestring
Mcule
Legal namestring
mcule.com Kft.
Websiteurl
mcule.com
Company typeenum
Private
Founded yearint
2014
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBudapest, Hungary
HQ citystring
Budapest
HQ countrystring
Hungary
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
drug discovery platform, virtual screening, compound sourcing, molecular modeling, lead optimization
NAICS code1 code
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518210
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Drug Discovery Platform
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Subscription Plans
TypeSubscription Recurring
Description

Tiered subscription model providing access to premium features including Instant Quote, Product Filters, and Supplier Data Downloads. Free tier available with limited basic tools access.

mcule.com
2Compound Sourcing/Procurement
TypeTransaction Fee
Description

Transaction-based revenue from procurement and delivery of chemical compounds sourced from multiple suppliers, consolidated into single-package delivery.

mcule.com
3Database Downloads
TypeSubscription Recurring
Description

Subscription-based access to download supplier data including catalog names, purity, and stock availability for all purchasable compounds.

mcule.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales
Pricing details1 tier
1Free Package - Basic hit identification and lead optimization tools
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free tier includes: Docking (Vina), Diversity selection, Basic property filter, 1-Click Docking, Property Calculator. Limited access to more powerful tools.

mcule.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1ULTIMATE Database
Description

High-quality purchasable compound database including ULTIMATE Express catalog with over 111 million compounds

mcule.com
+2 more records
Core offering1 text field

Mcule operates a cloud-based drug discovery platform that integrates the purchasable chemical space with molecular modeling tools. It offers three core modules — Hit Identification (virtual screening workflows and 1-Click Docking), Compound Sourcing (a curated database of 140M+ purchasable compounds with automated price optimization and consolidated single-package delivery), and Lead Optimization (property calculation and toxicity assessment). The platform is delivered as a self-serve web service with free and paid subscription tiers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 40% hit rate reported - 40% of initially tested compounds bound to target protein with high affinity
+2 more records
Product overview1 text field

Mcule is a cloud-based drug discovery platform that integrates purchasable chemical space with molecular modeling tools. The platform consists of three core modules: Hit Identification (virtual screening and workflow builder for finding new chemical starting points), Compound Sourcing (high-quality database with 140M+ purchasable compounds, Instant Quote, and automated price optimization), and Lead Optimization (1-Click Docking, Property Calculator, and Toxicity Checker for compound evaluation). The platform also offers specialized compound libraries (ULTIMATE, Natural Products, Building Blocks, Fragments, Kinase, GPCR, CNS, RNA-Binding, and others), Mcule KNIME nodes for workflow integration, and a Research Accelerator Program for academic users. Mcule serves pharmaceutical and biotech companies along with academic researchers, providing both free tier and subscription-based access to increasingly powerful tools.

Product and service2 records
1Mcule Online Drug Discovery Platform
CategoryCore Platform
Description

Integrated online platform combining purchasable chemical compound database with molecular modeling tools, enabling scientists to identify, optimize and order hits and leads for drug discovery projects.

2Hit Identification / Virtual Screening
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeTechnology or Integration
Description

Chemaxon provides chemical software development platforms and desktop applications for biotech and pharmaceutical industries. They offer leading-edge cross-platform solutions for cheminformatics and chemical communication.

Strategic tierCoreTypeTechnology or Integration
Description

Atomwise revolutionizes drug discovery with AI using deep learning for structure-based drug discovery. Their AtomNet technology has been used to unlock more undruggable targets than any other AI drug discovery platform.

Strategic tierCoreTypeTechnology or Integration
Description

Industry leader in computational molecular design based on decades of delivering rapid, robust, and scalable software and toolkits. Now integrated into Orion cloud-native molecular design platform.

Strategic tierCoreTypeTechnology or Integration
Description

Schrödinger's cloud-based enterprise informatics platform bringing together live cheminformatic data analysis and high throughput predictive modeling for accelerated molecular discovery projects.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Premier computational chemistry CRO with proven track record delivering high impact drug discovery projects. Integration of Mcule's purchasable compound library in Cresset Discovery's Blaze virtual screening platform provides greater chemical diversity for customers.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

European Union funding for ULTIMATE project - a major database initiative to create ultra-large purchasable compound catalogs for virtual screening.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

WuXi AppTec's CRDMO providing solutions for nucleic acids, peptides, and related synthetic conjugates. Offers 3,000+ catalog TIDES building blocks including nucleotides and Fmoc-amino acids.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Ukraine-based, privately held large-scale provider of building blocks, screening compounds (REAL database with billions of virtual compounds), and custom synthesis. Largest direct competitor in compound database scale; broader product portfolio than Mcule.

TypeEmerging player
Description

AI-driven structure-based drug discovery platform using deep learning (AtomNet) to identify novel compounds. Mcule partner but emerging AI-native competitor that may bypass traditional compound databases; overlap with Mcule's virtual screening customer base.

TypeBroad incumbent
Description

Scientific R&D informatics platform providing data management, ELN, and chemistry tools for pharma/biotech. Broader incumbent with overlapping enterprise cheminformatics and drug discovery data management use cases.

TypeBroad incumbent
Description

Hungary-headquartered cheminformatics software platform providing chemical drawing, search, registration, and database infrastructure for pharma/biotech. Mcule partner and overlapping Hungarian roots, but broader enterprise software scope.

TypeDirect peer
Description

US-based chemical compound sourcing platform aggregating catalogs from hundreds of suppliers with substructure search and procurement workflow. Direct peer to Mcule's compound sourcing business with overlapping pharma/biotech customer base.

TypeBroad incumbent
Description

Publicly traded computational chemistry and drug discovery software platform with LiveDesign, FEP+, and a broad pharma customer base. Broad incumbent in the cheminformatics space; also a Mcule partner, but with overlapping virtual screening capability.

TypeDirect peer
Description

Compound marketplace providing search, pricing, and procurement across building blocks, screening libraries, and custom synthesis. Direct peer to Mcule's compound sourcing and catalog aggregation offering.

TypeEmerging player
Description

Cloud-based drug discovery informatics platform (CDD Vault) providing compound registration, screening data management, and collaboration tools for academic and biotech researchers. Emerging player with overlapping academic/biotech customer segment and cheminformatics focus.

TypeBroad incumbent
Description

Computational chemistry software (Orion platform) serving pharma R&D with molecular design, docking, and cheminformatics tools. Mcule partner but also a broad incumbent with overlapping virtual screening and cheminformatics offerings.

TypeDirect peer
Description

Latvia-based online compound sourcing marketplace aggregating catalogs from 80+ suppliers with chemical search and procurement tools. Most direct peer to Mcule's compound marketplace business, with comparable supplier aggregation and search UX.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mcule

Drug Discovery Platformmcule.com

Mcule firmographics

Firmographics
Name
Mcule
Legal name
mcule.com Kft.
Website
https://mcule.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Where Mcule is headquartered

Location

Headquarters

HQ city
Budapest
HQ country
Hungary
HQ region
Europe

Offices3 records

Markets served

Mcule business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Subscription Plans: Tiered subscription model providing access to premium features including Instant Quote, Product Filters, and Supplier Data Downloads. Free tier available with limited basic tools access.
  2. Compound Sourcing/Procurement: Transaction-based revenue from procurement and delivery of chemical compounds sourced from multiple suppliers, consolidated into single-package delivery.
  3. Database Downloads: Subscription-based access to download supplier data including catalog names, purity, and stock availability for all purchasable compounds.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree Package - Basic hit identification and lead optimization tools

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Mcule product offering

Product offering

Core offering

Mcule operates a cloud-based drug discovery platform that integrates the purchasable chemical space with molecular modeling tools. It offers three core modules — Hit Identification (virtual screening workflows and 1-Click Docking), Compound Sourcing (a curated database of 140M+ purchasable compounds with automated price optimization and consolidated single-package delivery), and Lead Optimization (property calculation and toxicity assessment). The platform is delivered as a self-serve web service with free and paid subscription tiers.

Product overview

Mcule is a cloud-based drug discovery platform that integrates purchasable chemical space with molecular modeling tools. The platform consists of three core modules: Hit Identification (virtual screening and workflow builder for finding new chemical starting points), Compound Sourcing (high-quality database with 140M+ purchasable compounds, Instant Quote, and automated price optimization), and Lead Optimization (1-Click Docking, Property Calculator, and Toxicity Checker for compound evaluation). The platform also offers specialized compound libraries (ULTIMATE, Natural Products, Building Blocks, Fragments, Kinase, GPCR, CNS, RNA-Binding, and others), Mcule KNIME nodes for workflow integration, and a Research Accelerator Program for academic users. Mcule serves pharmaceutical and biotech companies along with academic researchers, providing both free tier and subscription-based access to increasingly powerful tools.

Differentiator

Problem solved

Functional benefit

Brands

  • ULTIMATE Database: High-quality purchasable compound database including ULTIMATE Express catalog with over 111 million compounds
  • MAC (mcule Advanced Curation)
  • Research Accelerator Program

Products and services

  • Mcule Online Drug Discovery Platform Integrated online platform combining purchasable chemical compound database with molecular modeling tools, enabling scientists to identify, optimize and order hits and leads for drug discovery projects.
  • Hit Identification / Virtual Screening

Quantifiable outcome

  • 40% hit rate reported - 40% of initially tested compounds bound to target protein with high affinity
  • +2 more outcomes

Companies that use Mcule

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Mcule technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability3 records

Feature7 records

Mcule partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core, flagship and minor.

  • ChemaxoncoreTechnology or IntegrationChemaxon provides chemical software development platforms and desktop applications for biotech and pharmaceutical industries. They offer leading-edge cross-platform solutions for cheminformatics and chemical communication.
  • AtomwisecoreTechnology or IntegrationAtomwise revolutionizes drug discovery with AI using deep learning for structure-based drug discovery. Their AtomNet technology has been used to unlock more undruggable targets than any other AI drug discovery platform.
  • OpenEye ScientificcoreTechnology or IntegrationIndustry leader in computational molecular design based on decades of delivering rapid, robust, and scalable software and toolkits. Now integrated into Orion cloud-native molecular design platform.
  • Schrödinger LiveDesigncoreTechnology or IntegrationSchrödinger's cloud-based enterprise informatics platform bringing together live cheminformatic data analysis and high throughput predictive modeling for accelerated molecular discovery projects.
  • Cresset DiscoverycoreStrategic or Co-development PartnerPremier computational chemistry CRO with proven track record delivering high impact drug discovery projects. Integration of Mcule's purchasable compound library in Cresset Discovery's Blaze virtual screening platform provides greater chemical diversity for customers.
  • European UnionflagshipStrategic or Co-development PartnerEuropean Union funding for ULTIMATE project - a major database initiative to create ultra-large purchasable compound catalogs for virtual screening.
  • WuXi TIDESminorStrategic or Co-development PartnerWuXi AppTec's CRDMO providing solutions for nucleic acids, peptides, and related synthetic conjugates. Offers 3,000+ catalog TIDES building blocks including nucleotides and Fmoc-amino acids.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Mcule competitors and assessment

Company assessment

Broad incumbents

  • Enamine: Ukraine-based, privately held large-scale provider of building blocks, screening compounds (REAL database with billions of virtual compounds), and custom synthesis. Largest direct competitor in compound database scale; broader product portfolio than Mcule.
  • Dotmatics: Scientific R&D informatics platform providing data management, ELN, and chemistry tools for pharma/biotech. Broader incumbent with overlapping enterprise cheminformatics and drug discovery data management use cases.
  • ChemAxon: Hungary-headquartered cheminformatics software platform providing chemical drawing, search, registration, and database infrastructure for pharma/biotech. Mcule partner and overlapping Hungarian roots, but broader enterprise software scope.
  • Schrödinger: Publicly traded computational chemistry and drug discovery software platform with LiveDesign, FEP+, and a broad pharma customer base. Broad incumbent in the cheminformatics space; also a Mcule partner, but with overlapping virtual screening capability.
  • OpenEye Scientific (Cadence Molecular Sciences): Computational chemistry software (Orion platform) serving pharma R&D with molecular design, docking, and cheminformatics tools. Mcule partner but also a broad incumbent with overlapping virtual screening and cheminformatics offerings.

Emerging players

  • Atomwise: AI-driven structure-based drug discovery platform using deep learning (AtomNet) to identify novel compounds. Mcule partner but emerging AI-native competitor that may bypass traditional compound databases; overlap with Mcule's virtual screening customer base.
  • Collaborative Drug Discovery (CDD): Cloud-based drug discovery informatics platform (CDD Vault) providing compound registration, screening data management, and collaboration tools for academic and biotech researchers. Emerging player with overlapping academic/biotech customer segment and cheminformatics focus.

Direct peers

  • eMolecules: US-based chemical compound sourcing platform aggregating catalogs from hundreds of suppliers with substructure search and procurement workflow. Direct peer to Mcule's compound sourcing business with overlapping pharma/biotech customer base.
  • ChemSpace: Compound marketplace providing search, pricing, and procurement across building blocks, screening libraries, and custom synthesis. Direct peer to Mcule's compound sourcing and catalog aggregation offering.
  • MolPort: Latvia-based online compound sourcing marketplace aggregating catalogs from 80+ suppliers with chemical search and procurement tools. Most direct peer to Mcule's compound marketplace business, with comparable supplier aggregation and search UX.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Mcule social profiles

Digital presence

Mcule financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mcule leadership team

Management profile

Number of profiles

Profiles12 records

Mcule funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mcule M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mcule

What does Mcule do?

Mcule operates a cloud-based drug discovery platform that integrates the purchasable chemical space with molecular modeling tools. It offers three core modules — Hit Identification (virtual screening workflows and 1-Click Docking), Compound Sourcing (a curated database of 140M+ purchasable compounds with automated price optimization and consolidated single-package delivery), and Lead Optimization (property calculation and toxicity assessment). The platform is delivered as a self-serve web service with free and paid subscription tiers.

Is Mcule a public or private company?

Mcule is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Mcule founded?

Mcule was founded in 2014. It employs 11 to 50 people.

Where is Mcule based?

Mcule is headquartered in Budapest, Hungary, in the Europe region.

How does Mcule make money?

Three revenue lines are on record. Subscription Plans are the primary driver. The others are compound Sourcing/Procurement and database Downloads.

Who are Mcule's main competitors?

Broad incumbents on record are Enamine, Dotmatics, ChemAxon, Schrödinger and OpenEye Scientific (Cadence Molecular Sciences). Emerging players are Atomwise and Collaborative Drug Discovery (CDD). Direct peers are eMolecules, ChemSpace and MolPort.

Does Mcule have an API?

Yes. Mcule offers an API for programmatic access to its compound database and services. The API documentation is available at doc.mcule.com. Specific details about protocol type, authentication method, rate limits, or versioning are not specified in the source material. Developer documentation is at doc.mcule.com/doku.php?id=api.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals